← Scroll for more →
Arbutus Biopharma Corp (ABUS)
Pharmaceutical Preparations
Latest Price
$4.28
TTM P/E
5.42
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
1.31
P/B Ratio
3.27
Institutional Ownership
69.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Two Seas Capital LP | 19.10M | $91.0M | 9.66% | +538.0K | 2026-06-30 |
| Morgan Stanley | 17.70M | $84.0M | 8.96% | -8.19M | 2026-06-30 |
| Whitefort Capital Management, LP | 15.79M | $75.0M | 7.99% | +863.4K | 2026-06-30 |
| BlackRock, Inc. | 13.77M | $66.0M | 6.97% | +799.1K | 2026-06-30 |
| State Street Corp | 7.87M | $37.0M | 3.98% | +1.53M | 2026-06-30 |
| Rubric Capital Management LP | 7.53M | $36.0M | 3.81% | +906.5K | 2026-06-30 |
| Vanguard Capital Management LLC | 7.01M | $33.0M | 3.55% | +321.8K | 2026-06-30 |
| Geode Capital Management, LLC | 4.12M | $19.0M | 2.08% | +345.9K | 2026-06-30 |
| Goldman Sachs Group Inc | 3.51M | $16.0M | 1.77% | +2.41M | 2026-06-30 |
| Bank of America Corp | 2.65M | $12.0M | 1.34% | +962.6K | 2026-06-30 |